Cardiopulmonary support and physiology
Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays

https://doi.org/10.1016/j.jtcvs.2004.08.031Get rights and content
Under an Elsevier user license
open archive

Objectives

The knowledge of chamber-specific gene expression in human atrial and ventricular myocardium is essential for the understanding of myocardial function and the basis for the identification of putative therapeutic targets in the treatment of cardiac arrhythmia and heart failure. In this study the gene expression pattern of human left atrial and ventricular myocardium was analyzed.

Methods

Global mRNA expression patterns with high-density oligonucleotide arrays between left atrial and left ventricular myocardium of 6 patients with heart failure undergoing heart transplantation were compared. Clustering of microarray data confirmed chamber-specific gene expression profiles. Genes similarly expressed in all patients were further analyzed, and data were confirmed by means of real-time polymerase chain reaction and Western blot analysis.

Results

Of 22,215 genes examined, 7115 transcripts were found to be expressed in all 12 human myocardial samples. One hundred twenty-five genes were differentially expressed between left atrial and left ventricular specimens in all patients examined. Novel genes preferentially expressed in human atria were identified. Interestingly, several potassium channels of subfamily K are more highly expressed in atria than in ventricles. Members of the potassium inwardly rectifying channel of subfamily J were found to be more highly expressed in human ventricular myocardium. Finally, chronic atrial fibrillation was associated with reduced atrial expression of the potassium channel TWIK-1, suggesting potential contribution of the corresponding current to electrical remodeling.

Conclusions

Human atria and ventricles show specific gene expression profiles. Our data provide the basis of a comprehensive understanding of chamber-specific gene expression in diseased human hearts and will support the identification of therapeutic targets in the treatment of arrhythmia and heart failure.

Cited by (0)

Ellinghaus and Morawietz (left to right)

This study was supported by the German Research Foundation (DFG; R. J. Scheubel, J. Holtz, and D. Dobrev) and the German Federal Ministry of Education and Research (BMBF) program NBL3 of the University of Technology Dresden (H. Morawietz, Professorship of Vascular Endothelium and Microcirculation) and the Atrial Fibrillation Network (BMBF grant 01 GI 0204, D. Dobrev).